Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Bruce Jackson reiterates a Speculative Buy rating on Cardio Diagnostics Hldgs (NASDAQ:CDIO) and maintains an $8 price target.
June 15, 2023 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bruce Jackson reiterates a Speculative Buy rating on Cardio Diagnostics Hldgs (NASDAQ:CDIO) and maintains an $8 price target.
The reiteration of a Speculative Buy rating by Benchmark analyst Bruce Jackson on Cardio Diagnostics Hldgs (NASDAQ:CDIO) and maintaining an $8 price target indicates a positive outlook for the stock. This news is directly related to CDIO and is important for investors as it suggests potential upside in the stock price. The confidence in the analysis is high due to the analyst's expertise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100